Integrating malaria vaccine and CRISPR/Cas9 gene drive: a comprehensive strategy for accelerated malaria eradication

Abstract Malaria remains a significant public health challenge, particularly in low- and middle-income countries, despite ongoing efforts to eradicate the disease. Recent advancements, including the rollout of malaria vaccines, such as RTS,S/AS01 and R21/Matrix-M™, offer new avenues for prevention....

Full description

Saved in:
Bibliographic Details
Main Authors: Israel Charles Abraham, John Ehi Aboje, Bonaventure Michael Ukoaka, Kehinde Tom-Ayegunle, Maryam Amjad, Anas Abdulkader, Chinonyelum Emmanuel Agbo, Oluwatosin Ayokunle Akinruli, Taiwo Rebecca Akisanmi, Emmanuel Oyedeji Oyetola, Gbolahan Olatunji, Emmanuel Kokori, Nicholas Aderinto
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Malaria Journal
Subjects:
Online Access:https://doi.org/10.1186/s12936-025-05243-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594981156552704
author Israel Charles Abraham
John Ehi Aboje
Bonaventure Michael Ukoaka
Kehinde Tom-Ayegunle
Maryam Amjad
Anas Abdulkader
Chinonyelum Emmanuel Agbo
Oluwatosin Ayokunle Akinruli
Taiwo Rebecca Akisanmi
Emmanuel Oyedeji Oyetola
Gbolahan Olatunji
Emmanuel Kokori
Nicholas Aderinto
author_facet Israel Charles Abraham
John Ehi Aboje
Bonaventure Michael Ukoaka
Kehinde Tom-Ayegunle
Maryam Amjad
Anas Abdulkader
Chinonyelum Emmanuel Agbo
Oluwatosin Ayokunle Akinruli
Taiwo Rebecca Akisanmi
Emmanuel Oyedeji Oyetola
Gbolahan Olatunji
Emmanuel Kokori
Nicholas Aderinto
author_sort Israel Charles Abraham
collection DOAJ
description Abstract Malaria remains a significant public health challenge, particularly in low- and middle-income countries, despite ongoing efforts to eradicate the disease. Recent advancements, including the rollout of malaria vaccines, such as RTS,S/AS01 and R21/Matrix-M™, offer new avenues for prevention. However, the rise of resistance to anti-malarial medications necessitates innovative strategies. This review explores the potential integration of CRISPR/Cas9 gene drive technology with malaria vaccination efforts to enhance vector control and reduce transmission. By employing gene drive mechanisms for population suppression and replacement of malaria-transmitting Anopheles mosquitoes, combined with the immunogenic properties of vaccines, a synergistic approach can be established. This paper discussed the need for integrated strategies to address the biological complexities of malaria and socio-economic factors influencing its prevalence. Challenges such as regulatory hurdles, community acceptance, ecological impacts, and sustainable funding are examined, alongside strategies for implementation within existing malaria control programmes. This integrated approach could significantly contribute to achieving the World Health Organization's targets for malaria reduction by 2030, ultimately enhancing public health outcomes and supporting broader socio-economic development.
format Article
id doaj-art-7f9187aa23784040bf5285f55122435d
institution Kabale University
issn 1475-2875
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj-art-7f9187aa23784040bf5285f55122435d2025-01-19T12:11:09ZengBMCMalaria Journal1475-28752025-01-012411710.1186/s12936-025-05243-7Integrating malaria vaccine and CRISPR/Cas9 gene drive: a comprehensive strategy for accelerated malaria eradicationIsrael Charles Abraham0John Ehi Aboje1Bonaventure Michael Ukoaka2Kehinde Tom-Ayegunle3Maryam Amjad4Anas Abdulkader5Chinonyelum Emmanuel Agbo6Oluwatosin Ayokunle Akinruli7Taiwo Rebecca Akisanmi8Emmanuel Oyedeji Oyetola9Gbolahan Olatunji10Emmanuel Kokori11Nicholas Aderinto12Department of Medicine and Surgery, University of IlorinBenue State University, College of Health SciencesDepartment of Internal Medicine, Asokoro District HospitalDept of Epidemiology & Biostatistics, Johns Hopkins Bloomberg School of Public HealthLiaquat National Hospital and Medical College KarachiCollege of Medicine, AlMaarefa UniversityDepartment of Pharmaceutical Sciences, University of NigeriaNational Health ServiceDepartment of Internal Medicine, State Hospital AbeokutaDepartment of Medicine, Ladoke Akintola University of TechnologyDepartment of Medicine and Surgery, University of IlorinDepartment of Medicine and Surgery, University of IlorinDepartment of Medicine, Ladoke Akintola University of TechnologyAbstract Malaria remains a significant public health challenge, particularly in low- and middle-income countries, despite ongoing efforts to eradicate the disease. Recent advancements, including the rollout of malaria vaccines, such as RTS,S/AS01 and R21/Matrix-M™, offer new avenues for prevention. However, the rise of resistance to anti-malarial medications necessitates innovative strategies. This review explores the potential integration of CRISPR/Cas9 gene drive technology with malaria vaccination efforts to enhance vector control and reduce transmission. By employing gene drive mechanisms for population suppression and replacement of malaria-transmitting Anopheles mosquitoes, combined with the immunogenic properties of vaccines, a synergistic approach can be established. This paper discussed the need for integrated strategies to address the biological complexities of malaria and socio-economic factors influencing its prevalence. Challenges such as regulatory hurdles, community acceptance, ecological impacts, and sustainable funding are examined, alongside strategies for implementation within existing malaria control programmes. This integrated approach could significantly contribute to achieving the World Health Organization's targets for malaria reduction by 2030, ultimately enhancing public health outcomes and supporting broader socio-economic development.https://doi.org/10.1186/s12936-025-05243-7MalariaVaccineCRISPR/Cas9Gene drive technology
spellingShingle Israel Charles Abraham
John Ehi Aboje
Bonaventure Michael Ukoaka
Kehinde Tom-Ayegunle
Maryam Amjad
Anas Abdulkader
Chinonyelum Emmanuel Agbo
Oluwatosin Ayokunle Akinruli
Taiwo Rebecca Akisanmi
Emmanuel Oyedeji Oyetola
Gbolahan Olatunji
Emmanuel Kokori
Nicholas Aderinto
Integrating malaria vaccine and CRISPR/Cas9 gene drive: a comprehensive strategy for accelerated malaria eradication
Malaria Journal
Malaria
Vaccine
CRISPR/Cas9
Gene drive technology
title Integrating malaria vaccine and CRISPR/Cas9 gene drive: a comprehensive strategy for accelerated malaria eradication
title_full Integrating malaria vaccine and CRISPR/Cas9 gene drive: a comprehensive strategy for accelerated malaria eradication
title_fullStr Integrating malaria vaccine and CRISPR/Cas9 gene drive: a comprehensive strategy for accelerated malaria eradication
title_full_unstemmed Integrating malaria vaccine and CRISPR/Cas9 gene drive: a comprehensive strategy for accelerated malaria eradication
title_short Integrating malaria vaccine and CRISPR/Cas9 gene drive: a comprehensive strategy for accelerated malaria eradication
title_sort integrating malaria vaccine and crispr cas9 gene drive a comprehensive strategy for accelerated malaria eradication
topic Malaria
Vaccine
CRISPR/Cas9
Gene drive technology
url https://doi.org/10.1186/s12936-025-05243-7
work_keys_str_mv AT israelcharlesabraham integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication
AT johnehiaboje integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication
AT bonaventuremichaelukoaka integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication
AT kehindetomayegunle integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication
AT maryamamjad integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication
AT anasabdulkader integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication
AT chinonyelumemmanuelagbo integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication
AT oluwatosinayokunleakinruli integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication
AT taiworebeccaakisanmi integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication
AT emmanueloyedejioyetola integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication
AT gbolahanolatunji integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication
AT emmanuelkokori integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication
AT nicholasaderinto integratingmalariavaccineandcrisprcas9genedriveacomprehensivestrategyforacceleratedmalariaeradication